| Literature DB >> 29061149 |
Maria Costanza Chiti1, Marie-Madeleine Dolmans2,3, Maria Hobeika1, Alice Cernogoraz1, Jacques Donnez4, Christiani Andrade Amorim1.
Abstract
BACKGROUND: Ovarian tissue cryopreservation followed by transplantation after cancer remission is the most commonly applied fertility restoration approach in very young girls and women who require immediate cancer therapy. However, clinicians strongly advise against reimplantation of one's own ovarian tissue when there is a high risk of recurrence after grafting. For these patients, development of an alternative strategy, namely a transplantable artificial ovary, offers future hope of conceiving. The first essential requirement for an artificial ovary is the set-up of a safe and effective follicle isolation procedure. Despite encouraging results with different variants of this technique, none of them take into the account the physiology and great variability in follicular density inside individual tissue fragments and between different patients. The goal of this study was to improve our previously applied follicle isolation procedure in order to develop a tailored isolation procedure for human follicles according to individual tissue properties. To this end, enzymatic digestion was divided into three time intervals in order to initially recover the first follicles to be isolated, and then further dissociate undigested fragments of tissue containing entrapped follicles.Entities:
Keywords: Artificial ovary; Fibrin matrix; Ovarian follicle isolation; Xenografting
Mesh:
Year: 2017 PMID: 29061149 PMCID: PMC5654051 DOI: 10.1186/s13048-017-0366-8
Source DB: PubMed Journal: J Ovarian Res ISSN: 1757-2215 Impact factor: 4.234
Follicle yield according to follicle isolation protocol. Individual follicle yield from 22 patients according to different follicle isolation protocols
| Patient | Established | Modified |
|---|---|---|
| 1 | 2 | 11 |
| 2 | 23 | 93 |
| 3 | 45 | 61 |
| 4 | 162 | 117 |
| 5 | 152 | 272 |
| 6 | 50 | 105 |
| 7 | 110 | 90 |
| 8 | 0 | 0 |
| 9 | 341 | 483 |
| 10 | 200 | 303 |
| 11 | 7 | 18 |
| 12 | 13 | 19 |
| 13 | 105 | 177 |
| 14 | 125 | 135 |
| 15 | 58 | 70 |
| 16 | 7 | 28 |
| 17 | 29 | 65 |
| 18 | 17 | 15 |
| 19 | 105 | 91 |
| 20 | 65 | 119 |
| 21 | 125 | 127 |
| 22 | 197 | 324 |
| Total | 1938 | 2732 |
Fig. 1Isolation of human preantral follicles. In the previous protocol, some follicles showed extruded oocytes (red arrow) (a); in the modified protocol, the vast majority of follicles were isolated from ovarian tissue samples (b). Distribution of isolated follicles in the modified protocol according to the three time intervals (c); some follicles remained entrapped in fragments of undigested tissue (black arrows) (d)
Follicle developmental stage after fibrin matrix encapsulation. Follicle developmental stages were compared between the previous and modified isolation protocols
| Number of follicle stage after fibrin encapsulation | ||
|---|---|---|
| Previous protocol (%) | Modified protocol (%) | |
| Primordial | 14 (7%) a | 18 (15%) b |
| Primary | 127 (66%) a | 90 (77%) b |
| Secondary | 53 (27%) c | 9 (8%) d |
Different letters (a, b, c, d) in each row indicate significant differences (a, b p < 0.05; c, d p < 0.01)
Fig. 2Histologically normal representations of human follicles encapsulated in a fibrin matrix. Primordial (a), primary (b) and secondary (c) follicles after isolation with the modified protocol and encapsulation in a fibrin matrix. An extruded oocyte (black arrow) (d) and normal and degenerated follicles (red arrow) were found with the previous protocol after histological analysis (e)
Fig. 3Follicle health status after caspase-3 and Ki67 immunohistochemistry. Caspase-3-negative primary follicles isolated with the established (a) and modified (b) isolation protocols. Ki67-positive follicles isolated with the established (c) and modified (d) isolation protocols
Distribution of Ki67-positive and -negative follicles according to the established and modified isolation protocols. Follicle developmental stages were compared between the previous and modified isolation protocols
| Follicle stage | Established ( | Modified ( |
| ||
|---|---|---|---|---|---|
| Ki67 + | Ki67 - | Ki67 + | Ki67 - | ||
| Primordial | 1a | 28 | 0a | 15 | 1.000 |
| (3.4%) | 0% | ||||
| Primary | 3b | 26 | 0b | 15 | 0.5402 |
| (10.3%) | 0% | ||||
| Secondary | 4c | 25 | 1c | 14 | 0.6467 |
| (13.8%) | 6.7% | ||||
Different letters (a, b, c) in each row indicate significant differences (a, b, c p < 0.05)
Fig. 4Grafting of a fibrin clot to the ovarian bursa of a SCID mouse. A fibrin clot containing human follicles and ovarian SCs isolated using the modified protocol before transplantation (a); xenografting of the fibrin clot to the ovarian bursa of a SCID mouse (b); histological representation of the fibrin clot inside the ovarian bursa of a SCID mouse after 7 days of transplantation: a follicle is visible in the middle of the fibrin clot (red arrow) (c); histological representation of follicles found in fibrin clot after 7 days of transplantation (red arrow) (d)